Agilent Technologies (A) Stock Forecast & Price Target

$110.92 -1.00 (-0.90%)

Closing price 03:59 PM Eastern

Extended Trading

$110.56 -0.36 (-0.33%)

As of 07:55 PM Eastern

Agilent Technologies - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 14 Analyst Ratings

Sell
0

Hold
7

Buy
7

Based on 14 Wall Street analysts who have issued ratings for Agilent Technologies in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 14 analysts, 7 have given a hold rating, and 7 have given a buy rating for A.

Consensus Price Target

$140.15
26.36% Upside

According to the 14 analysts' twelve-month price targets for Agilent Technologies, the average price target is $140.15. The highest price target for A is $165.00, while the lowest price target for A is $115.00. The average price target represents a forecasted upside of 26.36% from the current price of $110.92.

Get the Latest News and Ratings for A and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Agilent Technologies and its competitors.

A Analyst Ratings Over Time

Type	Current Forecast 6/2/24 to 6/2/25	1 Month Ago 5/3/24 to 5/3/25	3 Months Ago 3/4/24 to 3/4/25	1 Year Ago 6/3/23 to 6/2/24
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	7 Buy rating(s)	6 Buy rating(s)	7 Buy rating(s)	10 Buy rating(s)
Hold	7 Hold rating(s)	7 Hold rating(s)	7 Hold rating(s)	5 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	1 Sell rating(s)
Consensus Price Target	$140.15	$143.00	$146.15	$137.19
Forecasted Upside	26.36% Upside	31.58% Upside	18.71% Upside	5.20% Upside
Consensus Rating	Moderate Buy	Hold	Moderate Buy	Moderate Buy

A Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

A Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Agilent Technologies Stock vs. The Competition

Type	Agilent Technologies	Medical Companies	S&P 500
Consensus Rating Score	2.50	2.81	2.54
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	26.25% Upside	5,992.76% Upside	15.81% Upside
News Sentiment Rating	Positive News See Recent A News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
5/30/2025	Leerink Partners 1 of 5 stars		Boost Target	Buy	$135.00	+19.78%
5/29/2025	UBS Group 3 of 5 stars	Elizabeth Garcia Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Neutral ➝ Neutral	$150.00 ➝ $130.00	+13.99%
5/29/2025	JPMorgan Chase & Co. 2 of 5 stars	Tycho Peterson Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Overweight ➝ Overweight	$160.00 ➝ $155.00	+34.39%
5/29/2025	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy	$150.00	+29.52%
5/22/2025	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Catherine Schulte Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Outperform ➝ Outperform	$159.00 ➝ $140.00	+28.35%
4/21/2025	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Brandon Couillard Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Hold ➝ Hold	$135.00 ➝ $116.00	+16.44%
4/17/2025	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Brandon Couillard Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Overweight ➝ Overweight	$155.00 ➝ $135.00	+31.59%
4/10/2025	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	L. Sergott Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Equal Weight ➝ Equal Weight	$138.00 ➝ $115.00	+14.25%
12/19/2024	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	P. Donnelly Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Buy	$165.00	+23.96%
12/13/2024	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Neutral ➝ Neutral	$153.00 ➝ $150.00	+8.93%
Get the Latest News and Ratings for A and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Agilent Technologies and its competitors with MarketBeat's FREE daily newsletter.
11/26/2024	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Market Perform ➝ Market Perform	$140.00 ➝ $135.00	+1.41%
10/1/2024	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	In-Line ➝ In-Line	$135.00 ➝ $145.00	-0.46%
8/26/2024	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy	$151.00	+7.19%
6/27/2024	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	D. Schenkel Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Outperform ➝ Peer Perform
3/26/2024	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$67.00 ➝ $90.00	-38.30%
12/7/2023	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$128.00 ➝ $145.00	+12.47%
8/16/2023	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Outperform ➝ Outperform	$160.00 ➝ $150.00	+19.38%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 09:28 PM ET.

Should I Buy Agilent Technologies Stock? A Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Monday, June 2, 2025. Please send any questions or comments about these Agilent Technologies pros and cons to contact@marketbeat.com.

Agilent Technologies
Bull Case

Here are some ways that investors could benefit from investing in Agilent Technologies, Inc.:

The current stock price is around $111, reflecting a stable market position and potential for growth.
Agilent Technologies, Inc. reported a quarterly earnings per share (EPS) of $1.31, exceeding analysts' expectations, indicating strong financial performance.
The company has shown a year-over-year revenue increase of 6%, suggesting robust demand for its products and services in the life sciences and diagnostics sectors.
Agilent Technologies, Inc. has a solid market capitalization of approximately $31.85 billion, which can provide stability and investor confidence.
The firm has a reasonable dividend payout ratio of 24.44%, offering a dividend yield of 0.89%, which can be attractive for income-focused investors.

Agilent Technologies
Bear Case

Investors should be bearish about investing in Agilent Technologies, Inc. for these reasons:

The stock has experienced fluctuations, with a 52-week high of $153.84 and a low of $96.43, indicating potential volatility.
Agilent Technologies, Inc. has a relatively high price-to-earnings (P/E) ratio of around 27.60, which may suggest that the stock is overvalued compared to its earnings.
The company’s beta of 1.27 indicates that its stock price is more volatile than the market, which could pose risks for conservative investors.
Recent insider selling, including transactions by executives, may raise concerns about the company's future prospects and management confidence.
While the company has shown revenue growth, the competitive landscape in the life sciences sector is intense, which could impact future performance.

A Forecast - Frequently Asked Questions

: According to the research reports of 14 Wall Street equities research analysts, the average twelve-month stock price forecast for Agilent Technologies is $140.15, with a high forecast of $165.00 and a low forecast of $115.00.
: 14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Agilent Technologies in the last year. There are currently 7 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" A shares.
: According to analysts, Agilent Technologies's stock has a predicted upside of 26.36% based on their 12-month stock forecasts.
: Agilent Technologies has been rated by research analysts at Barclays, Jefferies Financial Group, JPMorgan Chase & Co., Leerink Partners, Robert W. Baird, TD Cowen, UBS Group, and Wells Fargo & Company in the past 90 days.
: Analysts like Agilent Technologies less than other "medical" companies. The consensus rating score for Agilent Technologies is 2.50 while the average consensus rating score for "medical" companies is 2.81. Learn more on how A compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top-Rated Stocks

More Ratings Tools

This page (NYSE:A) was last updated on 6/2/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Agilent Technologies (A) Stock Forecast & Price Target